Evidence map›Paper›PMID 33376147›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2021

Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6.

Kevin D McCarty, Samuel A Ratliff, Kyle A Furge, Laura Lowe Furge

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin D McCartyDepartment of Chemistry, Kalamazoo College, Kalamazoo, Michigan.
Samuel A RatliffDepartment of Chemistry, Kalamazoo College, Kalamazoo, Michigan.
Kyle A FurgeDepartment of Chemistry, Kalamazoo College, Kalamazoo, Michigan Laura.Furge@kzoo.edu.
Laura Lowe FurgeDepartment of Chemistry, Kalamazoo College, Kalamazoo, Michigan Laura.Furge@kzoo.edu.
Kalamazoo College · US

Funding

The Effect of Genetic Diversity on Mechanism-Based Inactivation of CYP2D6R15GM086767 · NIGMS · KALAMAZOO COLLEGE · PI FURGE, KYLE A, FURGE, LAURA L · 2009 to 2017
$1.1M
NIGMS NIH HHS R15 GM086767
6 · The paper itself

Abstract

CYP2D6 is a major drug metabolizing enzyme with a buried active site. Channels leading to the active site from various enzyme surfaces are believed to facilitate ligand egress and access to the active site. The present study used molecular dynamics (MD) and in vitro studies with CYP2D6*1 and a Trp75-to-Ala mutant to examine channel gating in CYP2D6 by Trp75. MD simulations measured energy landscapes of Trp75 conformations and simulated substrate passage within channel 2b using bufuralol as a model substrate. Trp75 alternated between multiple stable states that supported substrate transport along channel 2b with low-energy barriers between states (∼ -1 kcal/mol). Trp75 conformations were stabilized primarily by hydrogen bonding between Trp75 and Glu222, Asn226, Ala225, or Gln72. Energy barriers were low between Trp75 conformations, allowing Trp75 to easily move between various conformations over time and to function in both binding to and moving substrates in the 2b channel of CYP2D6. Michaelis-Menten kinetic studies completed with purified enzyme in a reconstituted system showed overall reduced enzyme efficiency for metabolism of bufuralol and dextromethorphan by the Trp75Ala mutant compared with CYP2D6*1. In stopped-flow measurements,

Indexed as

AnimalsCrystallography, X-RayCytochrome P-450 CYP2D6EthanolaminesIon Channel GatingProtein Structure, SecondaryRatsSubstrate SpecificityTryptophanbufuralolCytochrome P-450 CYP2D6EthanolaminesTryptophan

Identifiers

PMID33376147
PMCPMC7883074
OpenAlexW3113578470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.